Beatrice Weykopf specialized in her PhD on disease modeling of Parkinson’s disease using induced pluripotent stem cells (iPSC). The research was focused on identifying and assessing rapid and early disease relevant phenotypes in an iPS neuronal model of Parkinson’s disease using iPSCs from patients carrying a mutation in the LRRK2 gene. She recently joined the Neurogenomics lab and Parkinson Personalized Medicine Program of Dr. Clemens Scherzer.
